Market Access Views & Analysis

Views & Analysis

Market Access

Navigating NHS procurement processes: What start-ups need to...

The NHS finds itself in a very challenging place post-COVID, with unprecedented waiting lists, stretched finances, and a staffing crisis.

Market Access

12 questions with: Daniel Kohlstaedt

Daniel Kohlstaedt, managing director of PurpleLeaf Strategy, with more than 18 years of experience in pharma, talks about his journey through the industry.

Market Access

Has a biosimilar tipping point been achieved in the US?

As the biggest selling drug of all time begins to be hit by biosimilar competition, Ben Hargreaves asks whether biosimilars adoption could be about to take-off in the US.

Market Access